Copeland Capital Management LLC Grows Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

Copeland Capital Management LLC lifted its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 0.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 766,641 shares of the company’s stock after purchasing an additional 973 shares during the period. Copeland Capital Management LLC owned 0.05% of U.S. Physical Therapy worth $64,881,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Texas Permanent School Fund Corp increased its position in U.S. Physical Therapy by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock worth $1,480,000 after buying an additional 170 shares during the last quarter. First Horizon Advisors Inc. increased its holdings in U.S. Physical Therapy by 18.6% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock worth $110,000 after acquiring an additional 186 shares during the last quarter. Louisiana State Employees Retirement System raised its stake in U.S. Physical Therapy by 2.7% in the 2nd quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock valued at $702,000 after acquiring an additional 200 shares during the period. Martin Capital Advisors LLP lifted its holdings in U.S. Physical Therapy by 1.6% during the third quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock valued at $1,112,000 after purchasing an additional 201 shares during the last quarter. Finally, ProShare Advisors LLC boosted its position in U.S. Physical Therapy by 7.4% during the first quarter. ProShare Advisors LLC now owns 3,002 shares of the company’s stock worth $339,000 after purchasing an additional 206 shares during the period.

Wall Street Analyst Weigh In

A number of analysts recently commented on USPH shares. Bank of America restated a “neutral” rating and set a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. Barrington Research restated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research note on Wednesday, October 9th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $83.44 on Tuesday. The firm has a market capitalization of $1.26 billion, a P/E ratio of 78.72, a P/E/G ratio of 4.02 and a beta of 1.39. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.28. The stock’s 50-day simple moving average is $83.36 and its two-hundred day simple moving average is $93.09. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The company had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. During the same quarter last year, the firm posted $0.76 earnings per share. The firm’s revenue was up 10.4% on a year-over-year basis. As a group, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.58 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 2.11%. The ex-dividend date was Friday, August 23rd. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 166.04%.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Kathleen A. Gilmartin purchased 2,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was acquired at an average price of $86.09 per share, with a total value of $172,180.00. Following the transaction, the director now directly owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.